ãå°éºŠ(ã°ã«ãã³)ãšçµ±å倱調çã
çµ±å倱調çã®ã¯ã¹ãªãå¹æäžååã§ïŒããããæ粟ç¥ç è¬ã䜿ã£ãŠãã人ã¯ãå°éºŠã«å¯Ÿããæäœ(æã°ãªã¢ãžã³IgGæäœïŒAGA-IgG)æ¿åºŠãé«ãåŸåã§ãã£ããšããå ±åã§ããAGA-IgGãšã¯ãè¡æ¶²æ€æ»ã§ãããã°ã«ãã³æåæ§ã®å ç«åŠçããŒã«ãŒã§ãã
ã°ã«ãã³ãšã¯ããã³ããã¹ã¿ãªã©ã®å°éºŠç²ã®å 工補åãäœãäžã§å€§åãªã匟åæ§ãæè»æ§ã®ãã£ã¡ãæåã§ããå°éºŠç²ã®å Žåã6ïœ15 %ãããã±ã質ã§ããã®çŽ85%ã¯ã»ãŒåéã®ã°ãªã¢ãžã³ãšã°ã«ããã³ããæ§æãããŠããŸãã
ã°ã«ãã³æåæ§ïŒGluten SensitivityïŒGSïŒãšã¯ãç°¡åã«ãããšãå°éºŠãæåããããšã§ãå¿èº«ã«æªã圱é¿ãåºãŠããŸã人ã®ããšã§ããè ¹çã䟿ç§ãäžç¢ãæ䟿ç¿æ £ã®å€åãé çãç®èçºç¹ãé¢ç¯çãçèçãè³ã®é§ãç²åŽæãäžå®ãæãã€ãªã©ã
â AGA-IgGã°ã«ãŒãéœæ§ã®çµ±å倱調çã®æ²»çæµææ§(è¬ç©çæ³ãå¹æäžåå)ã®æ£è ã®æ°ã¯ãAGA-IgGã°ã«ãŒãé°æ§ã®æ£è ãããææã«å€ãã£ãïŒ82ïŒ vs39ïŒ ãP=0.017ïŒãå³å³
â¡æ²»çæµææ§ã®æ£è ã®AGA-IgGæ¿åºŠã¯ãæ²»çæµææ§ã®ãªãæ£è ãããææã«é«ãã£ãïŒ10.79 U/ml vs5.19 U/mlãP = 0.034ïŒãå·Šå³
â¢AGA-IgGéœæ§ã®æ£è ã¯ãAGA-IgGé°æ§ã®æ£è ãšæ¯èŒããŠå ¥é¢æŽãããåŸåïŒ73ïŒ vs 55ïŒ ãP = 0.079ïŒã
â£éœæ§AGA-IgG矀ã§ã¯ãé°æ§AGA-IgG矀ãããæCP(ã¯ãã«ããããžã³)æç®600 mg/æ¥ä»¥äžã®çšéã§æ粟ç¥ç è¬ãæäžãããæ£è ãææã«å€ãã£ãïŒ82ïŒ vs47ïŒ ãP=0.048ïŒã
ãšããçµæã§ããã
Motoyama M, Yamada H, Motonishi M et al.Elevated anti-gliadin IgG antibodies are related to treatment resistance in schizophrenia.Compr Psychiatry. 2019 Aug;93:1-6.
ã°ã«ãã³æåæ§ããã人ã®æ²»çã¯ãã°ã«ãã³ããªãŒé£ãšãªããŸãããå¯äœçšããªãã®ããããšããã§ããäžéšã®å¿èº«ã®çç¶ãç·©åãã人ããããããã°ã«ãã³ãšç²Ÿç¥çç¶ã®é¢ä¿ã¯ããŸããŸãé¢å¿ãé«ãŸã£ãŠããŸãã
ç§ã®å€æ¥ã§ã¯ãçµ±å倱調çã ãã§ãªããçºéé害ããã€ç¶æ ãæ ¢æ§ç²åŽãªã©ãã¯ã¹ãªããªããªãååãªå¹æããªã人ã¯ãã°ã«ãã³ããªãŒé£ïŒgluten-free dietïŒGFDïŒãæäœïŒé±éãè©ŠããŠããã£ãŠããŸãã
å³å¯ã«ãã£ã人ã®äžã§ãé ã®ãã£ããããªãæããé çãç²åŽæãæãã€ãªã©ãç·©åãã人ãããŸããããå€åãæãã人ã«ã¯ãå°éºŠãæ§ããé£ç掻ãããããããŠããŸãã
2019幎ç§ããå§ãŸãå µåº«å»ç§å€§åŠç²Ÿç¥ç§ç¥çµç§ã®ãã°ã«ãã³å€æ¥ãã¯ãä¿éºèšºçå ã§æã°ãªã¢ãžã³IgGæäœãè±ã¢ããåã°ãªã¢ãžã³ããããïŒDGPïŒæäœã®è¡æ¶²æ€æ»ããŠããã ããããšã«ãªãããã§ãã